<unk>  is an immune modulator that is FDA approved for the {{{indicationType}}} of relapsing forms of multiple sclerosis (MS).   Common adverse reactions include headache, influenza, diarrhea, back pain, liver transaminase elevations, and cough.
Fingolimod
Glatiramer
Glatiramer acetate
Riluzole
Laquinimod
Atezolizumab
Suxibuzone
Tofacitinib